MEETINGS - Seminar on FDA Approval Process for Medical Devices (UK) September 2002:
This article was originally published in Clinica
Executive Summary
Management Forum is hosting a seminar on the FDA Approval Process for Medical Devices on September 19-20 2002 at The Rembrandt Hotel, London, UK. The seminar will focus on new changes to the medical device regulations and provide an overview to the submission of documents to the FDA for approval of medical device products. It will include the requirements for an Investigational Device Exemption and the contents of a post-market approval as well as advice on maintaining an ongoing relationship with the FDA. Further details from Management Forum on tel: +44 (0)1483 570 099; fax: +44 (0)1483 536 424; email: [email protected] www.management-forum.co.uk
You may also be interested in...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.